Related Experiment Videos
Plasmodium falciparum merozoite surface protein 6 is a dimorphic antigen
J Andrew Pearce1, Tony Triglia, Anthony N Hodder
1Infection and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3050, Australia. pearce@wehi.edu.au
Infection and Immunity
|March 25, 2004
Summary
Merozoite surface protein 6 (MSP6) is dimorphic in Plasmodium falciparum, with distinct alleles found globally and in Southeast Asia. This dimorphism affects merozoite invasion and antibody responses, suggesting MSP6 as a potential malaria vaccine target.
Area of Science:
- Malariology
- Parasitology
- Immunology
Background:
- Merozoite surface protein 1 (MSP1) complex is crucial for Plasmodium falciparum erythrocyte invasion.
- MSP1 and other merozoite surface proteins exhibit dimorphism, influencing parasite virulence and immune evasion.
Purpose of the Study:
- To investigate the dimorphism of Merozoite surface protein 6 (MSP6), a component of the MSP1 complex.
- To determine the geographical distribution and functional implications of MSP6 dimorphism.
Main Methods:
- Sequence analysis of eight MSP6 genes from Plasmodium falciparum isolates.
- Characterization of MSP6 cleavage sites and antibody cross-reactivity.
Main Results:
- MSP6 exhibits dimorphism, with conserved 3D7-type alleles found globally and K1-type alleles restricted to Southeast Asia.
- MSP6 cleavage occurs at different sites for 3D7 and K1 alleles.
- Anti-3D7 MSP6 antibodies inhibited homologous parasite invasion but not K1-type parasites, indicating allele-specific immune responses.
Conclusions:
- MSP6 dimorphism is a significant factor in Plasmodium falciparum biology and immune interactions.
- MSP6 represents a potential target for malaria vaccines, with strategies needing to account for allelic variation.